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Abstract
Background: Hypoxic microenvironments in tumors contribute to transformation, which may alter metabolism, 
growth, and therapeutic responsiveness. The α-enolase gene encodes both a glycolytic enzyme (α-enolase) and a 
DNA-binding tumor suppressor protein, c-myc binding protein (MBP-1). These divergent α-enolase gene products play 
central roles in glucose metabolism and growth regulation and their differential regulation may be critical for tumor 
adaptation to hypoxia. We have previously shown that MBP-1 and its binding to the c-myc P2 promoter regulates the 
metabolic and cellular growth changes that occur in response to altered exogenous glucose concentrations.
Results: To examine the regulation of α-enolase and MBP-1 by a hypoxic microenvironment in breast cancer, MCF-7 
cells were grown in low, physiologic, or high glucose under 1% oxygen. Our results demonstrate that adaptation to 
hypoxia involves attenuation of MBP-1 translation and loss of MBP-1-mediated regulation of c-myc transcription, 
evidenced by decreased MBP-1 binding to the c-myc P2 promoter. This allows for a robust increase in c-myc expression, 
"early c-myc response", which stimulates aerobic glycolysis resulting in tumor acclimation to oxidative stress. Increased 
α-enolase mRNA and preferential translation/post-translational modification may also allow for acclimatization to low 
oxygen, particularly under low glucose concentrations.
Conclusions: These results demonstrate that malignant cells adapt to hypoxia by modulating α-enolase/MBP-1 levels 
and suggest a mechanism for tumor cell induction of the hyperglycolytic state. This important "feedback" mechanism 
may help transformed cells to escape the apoptotic cascade, allowing for survival during limited glucose and oxygen 
availability.
Background
It is clear that the tumor microenvironment influences
the rate of cell proliferation and may have a profound
effect on tumor progression and resistance to therapy
[1,2]. As a result of variable blood flow (oxygen supply)
and rapid utilization of glucose within solid tumors (oxy-
gen utilization), most tumor cells are subjected to a
microenvironment that is hypoxic and may be hypoglyce-
mic. These conditions likely contribute to tumor trans-
formation and growth [3,4]. Regional tumor hypoxia
develops in the early stages of carcinogenesis before
tumor metastasis, even non-invasive tumors may be
hypoxic [5,6]. Hypoxia is quite common in breast cancer
where it has been related to poor prognosis [7] with
increased risk for tumor recurrence and metastasis [8].
Transformed cells demonstrate increased levels of glyc-
olysis, which are associated with increased levels of glyco-
lytic enzyme mRNA and protein [59]. This results in the
production of, large amounts of lactic acid (Warburg
Effect) [10,11]. This increase in glycolytic metabolism,
mediated by Hif-1α and c-myc [12], provides transformed
cells with a selective growth advantage by circumventing
the normal oxygen dependency for ATP production.
Although the changes associated with increased glyco-
lytic enzyme mRNA and protein levels [5,9] have been
well documented, the exact mechanisms leading to
increased glycolysis and abnormal tumor cell growth
under hypoxic conditions are not completely understood.
Because of its frequent overexpression in transformed
cells, stimulatory effect on cell growth [13], and ability to
upregulate the transcription of several glycolytic enzymes
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[14] the "early response" gene, c-myc, has been implicated
in adaptation of transformed cells to hypoxia [15]. C-Myc
is known to be overexpressed in approximately 70% of all
human tumors [12]. One of the enzymes whose expres-
sion is upregulated by c-myc is α-enolase (48 KDa), which
catalyzes the conversion of 2-phosphoenolpyruvate from
2-phosphoglycerate [16]. α-Enolase is also a hypoxic
stress protein, which may contribute to hypoxic tolerance
of tumors by increasing anaerobic metabolism [17]. Its
overexpression in tumors at the RNA and protein level
has been associated with progression of tumors and poor
patient survival [18,19].
Interestingly, α-enolase mRNA also gives rise to a
shorter (37 KDa) alternative translation product, c-myc
binding protein (MBP-1). In contrast to α-enolase, MBP-
1 is a DNA binding protein and does not have enolase
activity. MBP-1 is preferentially localized in the cell
nucleus and negatively regulates c-myc transcription by
binding to the P2 promoter [20-22], the predominant c-
myc promoter in normal and transformed cells [23]. Con-
stitutive overexpression of MBP-1 reduces invasiveness
and colony formation in breast cancer cells, suppresses
tumor formation in nude mice [24], and regresses lung
tumor growth [25], indicating that it functions as a tumor
suppressor. Thus, the interactions between α-enolase,
MBP-1, and c-myc represent an important regulatory
intersection between energy metabolism and growth
control.
Cell proliferation and induction of the hyperglycolytic
state are regulated by levels of MBP-1 expression and its
binding to the c-myc P2 promoter in response to changes
in glucose concentration [26]. However, the differential
translation of α-enolase and MBP-1 and its relation to the
control of cell growth and metabolism under hypoxia has
not been characterized. To examine the regulation of α-
enolase and MBP-1 by a hypoxic microenvironment,
MCF-7 breast cancer cells were cultured under hypoxic
(1% O2) growth conditions in low (1 nM), physiological (5
mM), or high glucose (25 mM). The levels of expression
of α-enolase, MBP-1, and c-myc were compared to cell
proliferation and lactate production. This study provides
a new mechanism for the regulation of cell growth and
metabolism of transformed cells under hypoxia, demon-
strating that induction of α-enolase mRNA, preferential
translation of α-enolase over MBP-1, and inhibition of
MBP-1 function may all be involved in both promoting
survival of MCF-7 cells and stimulating cell growth under
substrate limitation.
Results
Cell proliferation and Viability
The effect of hypoxia on the proliferation of MCF-7 cells
grown in low (1 nM), physiological (5 mM), or high (25
mM) glucose concentrations was determined at 6, 24, and
48 h. Changes in proliferative rate and cellular viability
were assessed by trypan blue staining. After 6 h of
hypoxia, cell number increased modestly in MCF-7 cells
grown in 5 mM and 25 mM glucose and the increase was
maintained through 48 h (Fig. 1B). Trypan blue staining
demonstrated that the majority of these cells were viable
after 48 h of hypoxia (89.0 ± 1.1% and 89.2 ± 2.0% respec-
tively). In contrast, hypoxic cells grown in low glucose
grew much more slowly, however, the majority (93.7 ±
2.7%) of the cells remained viable. There was no signifi-
cant difference in cell number or viability between cells
grown in 5 mM or 25 mM glucose under hypoxia or nor-
moxia (Fig. 1A). However, MCF-7 cells grown in low glu-
cose demonstrated decreased proliferative rates under
both hypoxic and normoxic conditions.
Cell Cycle Analysis
Since no change in the rate of proliferation was seen in
MCF-7 cells grown under hypoxia at any glucose concen-
tration, we elected to characterize the effect of hypoxia
on cell cycle kinetics. Consistent with the data shown
Figure 1 Effect of hypoxia and different glucose concentrations 
on cell proliferation. Changes in cell proliferation after 6, 24, and 48 h 
of  normoxia (A) or hypoxia (B) in response to 1 nM (diamond), 5 mM 
(square), or 25 mM (triangle) glucose by trypan blue counting of cells. 
MCF-7 cells were plated (7.5X104/well) and cell counts and viability 
were measured. Data is mean ±SEM of 3 separate experiments.Sedoris et al. BMC Cancer 2010, 10:157
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above, there was very little effect of hypoxia on the cell
cycle distribution in cells grown in normal or high glu-
cose. On the other hand, cells grown in 1 nM glucose
demonstrated a significant G0/G1 arrest (data not shown).
This was seen in both normoxic and hypoxic cells, sug-
gesting that hypoxia, per se, does not significantly alter
cell cycle distribution. The observation that low glucose
inhibits cell proliferation is consistent with previously
reported results [26].
Lactate Production
In order to determine the effect of hypoxia on the glyco-
lytic rate at each glucose concentration, lactate produc-
tion by hypoxic cells was assessed over time. Hypoxic
MCF-7 cells grown in 1 nM glucose did not produce
detectable amounts of lactate from 4-24 h of hypoxia (Fig
2B), however at 48 h, a small amount of lactate was
detected. This modest level of lactate production was
abrogated when the cells were grown under the same
conditions without glutamine (data not shown).
In MCF-7 cells grown in physiologic (5 mM) and high
(25 mM) glucose, lactate increased at a linear rate with
large increases measured at 12, 24 and 48 h. When com-
pared to MCF-7 cells grown under normoxia [26],
hypoxic cells grown in 5 mM and 25 mM glucose pro-
duced roughly twice as much lactate from 12-48 h as did
normoxic cells (Fig 2A).
Hypoxia upregulates α-enolase mRNA and protein 
expression
In order to determine whether α-enolase is upregulated
in response to hypoxia, changes in α-enolase mRNA and
p r o t e i n  w e r e  m e a s u r e d  b y  R T - P C R  a n d  W e s t e r n  b l o t
analysis, respectively and compared to normoxic sam-
ples. A consistent increase in α-enolase mRNA was seen
after 12 to 48 h of hypoxia at all glucose concentrations
compared to normoxia. In response to hypoxia and low
glucose, α-enolase mRNA levels gradually increased until
t h e y  w e r e  s i g n i f i c a n t l y  e l e v a t e d  b y  m o r e  t h a n  2 . 5  f o l d
above normoxia at 48 h (Fig 3). At physiological glucose
concentrations, hypoxia immediately increased α-enolase
mRNA at 4 h, which continued to rise at 12 h and remain
elevated compared to normoxia through 48 h. With 25
mM glucose, hypoxic MCF-7 cells immediately increased
α-enolase mRNA after 4 h compared to normoxia. How-
ever, after 48 h, α-enolase mRNA increased over 3-fold
above normoxia. When compared to MCF-7 cells grown
under normoxic conditions [26], hypoxia significantly
increased the level of α-enolase mRNA at all glucose con-
centrations tested. This increase was maximal after 48 h
of hypoxia in cells grown in low or high glucose concen-
trations.
These changes in α-enolase transcript levels in
response to hypoxia were reflected in increased α-enolase
protein expression (Fig. 4A&B). In hypoxic cells grown
under low glucose conditions, there was a gradual
increase in α-enolase expression, culminating to a 6-fold
increase at 48 h compared to normoxia, which paralleled
the rise in α-enolase mRNA. In the normoglycemic (5
mM) cells, the increase in α-enolase protein concentra-
tion was more modest, reaching a 3-fold increase at 24 h
compared to normoxia and decreasing to 2-fold above
normoxia at 48 h. In hypoxic cells grown in 25 mM glu-
cose, α-enolase expression was initially decreased at 4 h
Figure 2 Lactate production (μM) in medium of MCF-7 cells growing in 1 nM (black bar), 5 mM (striped), or 25 mM (checkered) glucose after 
4, 6, 12, 24, or 48 h of normoxia (A) or hypoxia (B). Lactate concentrations were determined by detection of NAD-linked conversion of lactate to 
pyruvate by lactate dehydrogenase at 340 nM. Values are mean ± SEM from 3 separate experiments. * denotes a significant (p < 0.05) increase in lac-
tate compared to baseline. Note a 2-fold increase in lactate production with hypoxia and physiological or high glucose compared to normoxia. Nor-
moxia figure was previously published [26].Sedoris et al. BMC Cancer 2010, 10:157
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compared to normoxia, however, increased 4-fold com-
pared to normoxia at 24 h and decreased slightly to 3-fold
at 48 h. Thus, hypoxia induced a greater increase in α-
enolase protein expression by MCF-7 cells at lower con-
centrations of glucose (1 nM and 5 mM), although the
level of α-enolase mRNA was increased at all glucose
concentrations tested. This pattern is quite different from
normoxic cells grown in high glucose, which showed an
immediate rise in α-enolase protein expression and then
a sharp decrease from 6-48 h [26].
Changes in tyrosine phosphorylation of α-enolase with 
Hypoxia
Interestingly, α-enolase is one of only three glycolytic
enzymes which can undergo tyrosine phosphorylation in
transformed cells [27] and may be one mechanism by
which transformed cells respond quickly to changes in
ATP [28]. We decided to look at 6 h of normoxia and
hypoxia since α-enolase expression was elevated in the 1
nM and 5 mM groups in the absence of an increase in α-
enolase mRNA. After 6 h of hypoxia, there was a marked
increase in tyrosine phosphorylation of α-enolase in the
low glucose group compared to the 0 h normoxia control
(Fig 4C). In the 5 mM glucose group, tyrosine phosphory-
lation was also elevated compared to the 0 h normoxia
control, however the increase in phosphorylation was not
as great as in the low glucose group. After 6 h of hypoxia
in response to 25 mM glucose, tyrosine phosphorylation
of α-enolase was not increased. Therefore, the increase in
tyrosine phosphorylation of α-enolase at 6 h in response
to hypoxia was dependent on glucose concentration,
since increased tyrosine phosphorylation of α-enolase
was also measured under normoxic conditions. These
results suggest that the early hypoxia-induced changes in
α-enolase protein expression may be mediated by post-
translational modifications, which are influenced by glu-
cose concentration.
Effect of Hypoxia on MBP-1 Expression
Since α-enolase and MBP-1 are products of the same
mRNA, it is important to compare the effect of hypoxia
on both translation products. Indeed, there was an inter-
esting dichotomy in the effect of hypoxia on MBP-1
expression. Hypoxic cells grown in low glucose demon-
strated a small, gradual increase in MBP-1 levels, which
culminated to a peak at 24 h (Fig 5). By 48 h, MBP-1 levels
had fallen to expression levels comparable to baseline.
This is in marked contrast to normoxia, which showed a
robust increase in MBP-1 expression that was maintained
through 48 h. On the other hand, hypoxic cells grown in
normal or high glucose, demonstrated an initial increase
in MBP-1 expression, with a rapid, subsequent decline to
baseline levels. Therefore, hypoxia attenuated MBP-1
expression at all glucose concentrations, however, the
higher the glucose concentration, the faster the rate of
decline in MBP-1.
Hypoxia induces preferential translation of α-enolase
It is important to compare changes in the α-enolase/
MBP-1 ratio in order to determine whether hypoxia may
differentially affect the translation of either α-enolase or
MBP-1. With hypoxic cells grown in low glucose, equal
amounts of MBP-1 and α-enolase were translated ini-
tially, however, the delayed rise in MBP-1 expression at 12
h decreased the ratio to 0.79 at 12 h. After 24 and 48 h, α-
enolase was preferentially translated over MBP-1 culmi-
nating to a ratio of 2.87 at which point hypoxic cells
grown in low glucose start to proliferate (Fig 1). In
hypoxic cells grown under both physiologic and high glu-
cose conditions, there was an almost immediate decrease
in the α-enolase/MBP-1 ratio (0.36 and 0.44 at 4 h,
Figure 3 Time course of a-enolase mRNA after 4, 6, 12, 24, or 48 h of hypoxia in response to 1 nM, 5 mM, or 25 mM glucose by RT-PCR. All 
measurements were standardized with β-actin (loading control) and expressed as a ratio to the 0 h (expression ratio). Bars represent mean ± SEM from 
3 separate experiments. * denotes a significant (p < 0.05) increase in mRNA compared to normoxia. Note increased α-enolase transcripts after 12-48 
h of hypoxia with 1 nM, 5 mM, or 25 mM glucose. Normoxia data was previously published [26].Sedoris et al. BMC Cancer 2010, 10:157
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respectively) reflecting, primarily, a significant increase
in MBP-1 expression. This was followed by a steady
increase in the ratio at 48 h to 1.89 and 1.81 respectively,
reflecting increased levels of enolase and a relative
decrease in MBP-1 concentration. The immediate spike
in MBP-1 expression and later increase in α-enolase in
hypoxic cells grown in normal and high glucose concen-
trations is consistent with the delay in cellular prolifera-
tion (Fig 1). Under normoxic conditions at all glucose
concentrations, the α-enolase/MBP-1 ratio is consistently
less than 1.0 indicating that, MBP-1 is preferably trans-
lated over α-enolase [26]. These results indicate that
hypoxia induces preferential translation of α-enolase at
all glucose concentrations at 24 and 48 h, however the
greatest increase in the α-enolase/MBP-1 ratio occurred
with 1 nM glucose.
Effect of Hypoxia on c-myc expression
The alternative α-enolase translation product, MBP-1,
negatively regulates c-myc transcription. In order to char-
Figure 4 Changes in α-enolase protein expression after hypoxia in response to 1 nM, 5 mM, or 25 mM glucose. A) Western blots of α-enolase 
and β-actin (loading control) from total cell lysates. B) Histogram of α-enolase expression after 4, 6, 12, 24, or 48 h of hypoxia. Bars represent mean ± 
SEM expressed as a ratio to 0 h from 3 separate experiments. * denotes a significant (p < 0.05) increase in the level of expression.. Note greater induc-
tion of α-enolase expression after 48 h of hypoxia at all glucose concetrations compared to normoxia, especially with 1 nM glucose. Normoxia data 
was previously published [26]. C) Tyrosine phosphorylation of α-enolase after 6 h of hypoxia or normoxia with 1 nM, 5 mM, or 25 mM glucose. Total 
lysates were immunoprecipitated with α-enolase and immunoblotted with phosphotyrosine. Efficiency and specificity of the immunoprecipitations 
were verified by equal immunoprecipitation of α-enolase and an absence of α-enolase in samples immunoprecipitated with goat IgG. Note increased 
tyrosine phosphorylation of α-enolase in response to 1 mM or 5 mM glucose with hypoxia or normoxia.Sedoris et al. BMC Cancer 2010, 10:157
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acterize the physiologic effect of hypoxia induced MBP-1,
corresponding changes in c-myc mRNA were assessed by
RT-PCR. There was a 5-fold rise in c-myc mRNA in
hypoxic cells grown in 1 nM glucose as early as 4 h com-
pared to normoxia (Fig 6). However, c-myc transcript lev-
els decreased to 2-fold above baseline, nearly the same as
normoxic levels from 24-48 h. The pattern of the c-myc
response was the same but less prominent in cells grown
in physiologic and high glucose, reaching 2.5-fold above
normoxia. These results suggest that hypoxia stimulates
an early (4-6) increase in c-myc mRNA at all glucose lev-
els tested, The level of induction was about 2-fold greater
in the low glucose group compared to normal and high
glucose.
To determine whether changes in c-myc mRNA levels
paralleled changes in c-myc protein, c-myc expression
Figure 6 Hypoxia-induced changes in c-myc mRNA in response to 1 nM, 5 mM, or 25 mM glucose at 4, 6, 12, 24, or 48 h by RT-PCR. All mea-
surements were standardized with β-actin (loading control) and expressed as a ratio to the 0 h (expression ratio). Bars represent mean ± SEM from 3 
separate experiments. * denotes a significant (p < 0.05) increase in mRNA compared to normoxia. Note the early robust increase in c-myc transcripts 
in response to hypoxia that was greatest with 1 nM glucose. No early increase in c-myc mRNA occurred with normoxia. Normoxia data was previously 
published [26].
Figure 5 Effect of hypoxia on MBP-1 protein expression in response to 1 nM, 5 mM, or 25 mM glucose. A) Western blots of MBP-1 and β-actin 
(loading control) from total cell lysates. B) Histogram of MBP-1 expression after 4, 6, 12, 24, or 48 h of hypoxia. Bars represent mean ± SEM expressed 
as a ratio to 0 h from 3 separate experiments. * denotes a significant (p < 0.05) increase in expression and # denotes a significant decrease compared 
to normoxia. Note the brief, early increase in MBP-1 expression in cells exposed to hypoxia and 5 mM or 25 mM glucose and the brief, late increase in 
MBP-1 expression with hypoxia and 1 nM glucose. Overall, hypoxia attenuated MBP-1 expression at all glucose concentrations compared to normoxia. 
Normoxia data was previously published [26].Sedoris et al. BMC Cancer 2010, 10:157
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was assessed by Western blot analysis. Hypoxic cells
grown in low glucose demonstrated a robust increase in
c-myc protein expression after 4 h, which gradually
decreased to baseline levels by 48 h, a pattern very similar
to normoxia (Fig 7). With hypoxic cells grown in 5 mM
glucose, the initial c-myc response was less prominent
and markedly decreased compared to normoxia. When
hypoxic cells were grown in 25 mM glucose, the early
increase in c-myc expression was attenuated and not dif-
ferent from baseline. These results indicate tha t c -m yc
protein expression is induced early in response to
hypoxia with lower levels of glucose (1 nM and 5 mM) in
parallel with increased c-myc mRNA. However, hypoxia
with 25 mM glucose prevented the early increase in c-
myc expression. Both 5 mM and 25 mM glucose with
hypoxia induced a later increase (24 h) in c-myc expres-
sion independent of an increase in c-myc transcripts.
Hypoxia increases the production of ROS
To determine whether the early increase in c-myc mRNA
was associated with an increase in oxidative stress, we
assessed changes in intracellular ROS. The ROS levels
were assessed with DCFH-DA, which forms the fluores-
cent compound DCF when oxidized. Hypoxic cells dem-
onstrated an early increase in intracellular ROS
generation at all glucose concentrations, compared to
normoxic cells (Fig 8). After 4 h of hypoxia, intracellular
ROS production increased by more than 25-fold in cells
grown in low glucose, 15-fold in physiologic glucose, and
8-fold in high glucose. At all times, the level of ROS was
great in hypoxic cells compared to cells grown under nor-
moxia. Clearly, hypoxia increased intracellular ROS pro-
duction, particularly in cells grown in low glucose. Higher
concentrations of glucose attenuated the increase in ROS
production under hypoxia and normoxia.
Hypoxia reduces MBP-1 binding to the c-Myc P2 Promoter
MBP-1 has previously been shown to bind to a DNA
sequence containing the TATA box of the c-myc P2 pro-
moter and downregulate its transcription. Since hypoxia
caused an early induction in c-myc transcripts and MBP-
1 is a negative regulator of c-myc transcription, we were
interested in whether a change in MBP-1 binding to the
c-myc P2  promoter occurred. This question was
addressed by EMSA using a 50 bp 32P-labeled oligonucle-
otide relative to the P2 start site on the c-myc promoter
(Fig. 9A). A DNA-protein complex was visualized by
autoradiography, and its specificity was confirmed when
the complex was disrupted with 150 nM excess of cold
MBP-1 competitor (MP2), but not with 150 nM excess of
the cold non-specific competitor BEE-1. After 4 h of
Figure 7 Changes in c-myc protein expression after hypoxia in response to 1 nM, 5 mM, or 25 mM glucose. A) Western blots of c-myc and β-
actin (loading control) from total cell lysates. B) Histogram of c-myc expression after 4, 6, 12, 24, or 48 h of hypoxia. Bars represent mean ± SEM ex-
pressed as a ratio to the 0 h from 3 separate experiments. * denotes a significant (p < 0.05) increase in expression and # denotes a significant decrease 
compared to normoxia. Note attenuation of the early increase in c-myc protein in response to 5 mM or 25 mM glucose with hypoxia. Normoxia data 
was previously published [26].Sedoris et al. BMC Cancer 2010, 10:157
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hypoxia with 1 nM glucose, there was little difference in
P2 promoter binding compared to the 0 h normoxic con-
trol. However, the addition of hypoxia prevented the
increase in promoter binding previously seen with nor-
moxia [26]. After 24 h of hypoxia with low glucose, MBP-
1 binding to the P2 promoter decreased slightly, although
MBP-1 expression was elevated. On the other hand,
although MBP-1 protein expression was elevated after 4 h
of hypoxia with 5 mM and 25 mM glucose, binding to the
P2 promoter was decreased compared to 0 h, similar to
normoxia. However, after 24 h of hypoxia, MBP-1 bind-
ing to the P2  promoter drastically decreased and the
greatest reduction in binding was measured with 25 mM
glucose. This decrease in binding was greater with
hypoxia compared to normoxia Therefore, hypoxia mark-
edly decreased binding of MBP-1 to the c-myc P2 pro-
moter coincident with the increase in c-myc transcripts.
An α-enolase polyclonal antibody was able to bind and
supershift the DNA-protein complex and could be effec-
tively competed with excess MP2 but not BEE-1, further
demonstrating specificity of the shifted complex (Fig. 9B).
Effect of glucose concentration and hypoxia on Glut-1 
mRNA expression
Glut-1 is a glucose transporter markedly induced by
hypoglycemia [26]. It is also an ideal candidate gene
which may be involved in the cellular response to hypoxia
and altered glucose concentrations. Changes in glut-1
mRNA were assessed with RT-PCR (Fig. 10). In hypoxic
cells grown in 1 nM glucose, there was an almost imme-
diate 2-fold increase in glut-1 transcription that reached
3-fold greater than normoxia by 48 h. In hypoxic cells
grown in physiologic or high glucose, there was also an
immediate increase in glut-1 mRNA reaching about 2-
Figure 8 Effect of hypoxia on ROS production in response to 1 
nM, 5 mM, or 25 mM glucose. ROS production was measured in me-
dia and in cells after 0.5, 1, or 4 h of hypoxia (square) or normoxia (tri-
angle) by the conversion of 2',7'-dichlorofluorescin diacetate (DCFH-
DA) to 2',7'-dichlorofluorescein (DCF) and expressed as a percent of the 
0 h. Note increased ROS production with hypoxia compared to nor-
moxia, which was greatest at 4 h with 1 nM glucose.
Figure 9 Influence of hypoxia on P2 promoter binding by c-myc 
promoter binding protein in response to 1 nM, 5 mM, or 25 mM 
glucose as determined by electrophoretic mobility shift assay. A) 
A 50 base pair c-myc P2 promoter was 32P-labeled and incubated with 
nuclear extract (NE). Cold competitor MP2 (150 nM) (Lane 9) or cold 
nonspecific oligonucleotide BEE-1 (150 nM) (Lane 10) was added prior 
to addition of the probe. Note that MBP-1 binding to the probe with 1 
nM glucose was similar to the 0 h after 4 and 24 h of hypoxia. This is in 
contrast to normoxia data which showed an early increase in binding 
compared to baseline. Binding was greatly reduced in the 5 mM and 
25 mM groups after 4 and 24 h of hypoxia compared to normoxia. B) 
An α-enolase antibody was added to a reaction containing the nuclear 
extract and 32P-labeled P2 promoter (lane 3) causing a supershift of the 
DNA-protein complex. This supershift was competed off with MP2 
cold competitor (lane 4), but not with the cold nonspecific competitor 
BEE-1 (lane 5). No supershift occurred with addition of rabbit IgG to the 
reaction in place of antibody (lane 6). Normoxia figure was adapted 
and previously published [26].Sedoris et al. BMC Cancer 2010, 10:157
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fold greater than normoxia, however the overall response
by 48 h was less dramatic than that seen with hypoxia and
low glucose. Therefore, hypoxia stimulated an increase in
glut-1 transcripts at all glucose concentrations compared
normoxia. However, cells grown under hypoxia in low
glucose induced the greatest increase in glut-1 transcrip-
tion after 48 h.
Discussion
Even in the presence of adequate oxygen, transformed
cells metabolize the majority of the glucose they take up
through glycolysis [29]. This results in an "addiction" to
glucose as the source of ATP production, while available
lipids and amino acids are redirected for use in anabolic
synthesis [30]. C-Myc regulates many genes that are
responsible for these metabolic differences between nor-
mal and malignant cells. However, the exact molecular
mechanism by which the "aerobic glycolysis" of cancer
cells (Warburg effect) offers a selective growth advantage
for tumors remains unclear.
We have previously reported that the alternative trans-
lation product of the glycolytic enzyme α-enolase, MBP-
1, functions as a tumor suppressor because of its ability to
bind to the c-myc promoter and downregulate c-myc
mRNA and inhibit cellular proliferation [31]. Recently, we
determined that both expression and function of MBP-1
are regulated by alterations in exogenous glucose concen-
trations and correspond to changes in cell proliferation
and lactate production [26]. However, the differential
translation of α-enolase and MBP-1 and its relation to the
control of cell growth and metabolism under hypoxia
have not been characterized.
The c-myc oncogene plays an important role during the
cellular response to hypoxia to help achieve oxygen
homeostasis which is required for cell survival, promot-
ing glucose transport and enhanced glycolysis [32]. The
α-enolase gene, which encodes a glycolytic enzyme (α-
enolase) whose expression is stimulated by c-myc, and a
DNA binding protein (MBP-1), which binds the c-myc
promoter and downregulates c-myc expression, is in a
unique position to integrate the cellular response to
hypoxia. Our data support the hypothesis that preferen-
tial translation of α-enolase and inhibition of MBP-1
function play a role in the adaptation of MCF-7 cells to
low oxygen, particularly under low glucose conditions.
This adaptation is likely to be critical for the progression
and metastasis of tumor cells.
The role of MBP-1 in the hypoxic response is evidenced
in several ways. Hypoxic MCF-7 cells have a normal
growth rate, except in low glucose, suggesting that they
have developed molecular adaptations to hypoxia. This
suggests that in these transformed cells, enhanced glu-
cose utilization allows proliferation, even in hypoxic con-
ditions. This is reflected in the increased lactate
production by the hypoxic cells in normal and high glu-
cose concentrations compared to normoxia. On the other
hand, hypoxic cells grown in low glucose demonstrated
both a decreased growth and rate of lactate production.
It has been previously reported that expression of α-
enolase is stimulated by hypoxic conditions and that this
increase is mediated by both c-myc and Hif-1α since the
Hif-1α binding site in the α-enolase promoter (ChoRE,
carbohydrate response element) overlaps with the c-myc
E-box binding site [33]. As a glycolytic pathway enzyme,
this stimulation serves to increase the overall level of gly-
colysis in response to low oxygen availability. However, in
contrast to the other glycolytic pathway enzymes, the α-
enolase gene also encodes a tumor suppressor gene,
MBP-1, which downregulates c-myc expression [20]. Our
data confirms that hypoxia stimulates α-enolase mRNA
Figure 10 Hypoxia-induced changes in glut-1 mRNA in response to 1 nM, 5 mM, or 25 mM glucose at 4, 6, 12, 24, or 48 h by RT-PCR. All mea-
surements were standardized with β-actin (loading control) and expressed as a ratio to the 0 h (expression ratio). Bars represent mean ± SEM from 3 
separate experiments. * denotes a significant (p < 0.05) increase in mRNA compared to normoxia. Note early stimulation of glut-1 transcripts in re-
sponse to hypoxia and the robust increase in glut-1 mRNA at 48 h with 1 nM glucose. No early increase in glut-1 transcripts occurred with normoxia. 
Normoxia data was previously published [26].Sedoris et al. BMC Cancer 2010, 10:157
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levels at all glucose concentrations compared to nor-
moxia. This increase was more pronounced in hypoxic
cells grown in low (6-fold) and high (3-fold) glucose con-
centrations. The increase in α-enolase mRNA in response
to hypoxia at all glucose concentrations resulted in a cor-
responding increase in α-enolase protein and the α-eno-
lase/MBP-1 ratio compared to normoxia. Since lactate
production increased in the medium of the 5 mM and 25
mM hypoxia groups concurrently with the rise in α-eno-
lase mRNA and protein expression suggests a possible
contribution of α-enolase to the hyperglycolytic rate of
cancer cells.
MCF-7 cells grown in normoxic conditions with low
glucose demonstrated an early (4 h) increase in MBP-1
expression [26] which was accompanied by a striking
increase in MBP-1 binding activity to the c-myc promoter
by EMSA analysis. On the other hand, hypoxic cells had
an attenuated MBP-1 response at all glucose concentra-
tions compared to normoxia. In accordance with the
attenuated changes in MBP-1 protein expression in
hypoxic cells, binding of MBP-1 to the c-myc P2 promoter
was unchanged in relation to the 0 h control. In contrast,
hypoxic cells grown in physiologic or high glucose dem-
onstrated a short-lived increase in MBP-1 expression at
4-6 h. This was followed by a return to baseline levels and
a marked decrease of MBP-1 binding to the c-myc P2 pro-
moter, corresponding to a steady increase in proliferation
through 48 h. MCF-7 cells exposed to physiological or
high glucose with hypoxia are rapidly proliferating and
metabolizing glucose. An early increase in MBP-1 expres-
sion may serve to initially limit cell proliferation to allow
for upregulation of alternative metabolic pathways lead-
ing to production of lactate. This strong inverse correla-
tion between MBP-1 expression levels and rate of cellular
proliferation is consistent with previous reports that it
functions as a tumor suppressor in breast and prostate
cancer cells [24,34].
Although the absolute concentration of α-enolase pro-
tein was higher than MBP-1 under all conditions, the rel-
ative levels of translation of the two enolase gene
products were quite different. Initially, under conditions
of normal and high glucose, in the presence of increased
α-enolase mRNA, the concentration of MBP-1 was
increased over α-enolase, suggesting preferential transla-
tion of MBP-1. On the other hand, initially at low glucose
concentrations, MCF-7 cells had similar increases in α-
enolase and MBP-1, suggesting that these cells, under
considerable metabolic stress increased the level of both
gene products. However, at 48 h, α-enolase was preferen-
tially translated above the levels measured for normal and
high glucose.
In general, hypoxic cells demonstrated changes in c-
myc mRNA which were consistent with their levels of
MBP-1 expression and c-myc promoter binding. For
example, in hypoxic cells grown in low glucose, the failure
o f  t h e s e  c e l l s  t o  g e n e r a t e  a n  e a r l y  i n c r e a s e  i n  M B P - 1
allowed the corresponding robust 5-fold increase in c-
myc expression. This is consistent with studies which
h a v e  s h o w n  r e g u l a t i o n  o f  c - m y c  m R N A  b y  M B P - 1
expression and binding to the c-myc P2 promoter in nor-
moxic cells [26]. These results are consistent with the role
of c-myc as an "early response" gene whose transcript is
stimulated immediately with hypoxia (2-6 fold depending
on the tissue type) [35].
On the other hand, c-myc protein expression also paral-
leled c-myc transcript levels in cells grown in 5 mM glu-
cose and hypoxia. The failure of these cells to mount an
early MBP-1 response allowed a 2-fold increase in c-myc
mRNA, which corresponded to a 2-fold increase in pro-
tein expression and resulted in cellular proliferation.
Together, these results suggest that hypoxia in the pres-
ence of low glucose attenuates translation of MBP-1 and
disrupts MBP-1-mediated regulation of c-myc transcrip-
tion by inhibiting binding of MBP-1 to the c-myc P2 pro-
moter. Since c-myc is deregulated in most cancers [36],
inhibition of MBP-1 function may be one mechanism
which perpetuates c-myc overexpression at the mRNA
and protein level. Inhibition of MBP-1 function may also
decrease the susceptibility of cells to apoptosis as shown
with human fibroblasts [37], and carcinoma [38]. There-
fore, loss of MBP-1 function may be an important adapta-
tion which allows transformed cells to survive under
limited glucose and oxygen availability.
Interestingly, α-enolase is one of only three glycolytic
enzymes which undergo tyrosine phosphorylation in
transformed cells, however, the significance of this phos-
phorylation is unknown [39]. In this study, increased
tyrosine phosphorylation of α-enolase was observed in
hypoxic cells grown in low and normal glucose levels,
corresponding to the early rise in α-enolase protein
expression. This may be a mechanism by which trans-
formed cells respond quickly to changes in ATP [27],
although the significance of α-enolase tyrosine phospho-
rylation remains unclear. Several reports have shown
direct correlations between increased expression of eno-
lase both at the RNA and protein level and the progres-
sion of tumors [40]. These results suggest that hypoxia
induces preferential translation of α-enolase over MBP-1
and may be important for early tumor cell adaptation to
oxidative stress.
Several studies have shown that hypoxia increases the
production of ROS and depletes ATP [41], which may
increase c-myc transcription "early c-myc response" [42].
In the current study, hypoxia drastically increased intrac-
ellular ROS at all glucose concentrations after 4 h com-
pared to normoxic conditions, corresponding to the
robust increase in c-myc mRNA. However, transcript lev-
els of c-myc mRNA after 4 h of hypoxia were particularlySedoris et al. BMC Cancer 2010, 10:157
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elevated for the 1 nM glucose group and corresponded
with greater ROS production compared to the 5 mM and
25 mM glucose groups. Since glucose deprivation results
in mitochondrial dysfunction and enhances cellular sen-
sitivity to oxidative stress, robust quantities of ROS are
produced [43,44] resulting in higher levels of c-myc
mRNA. Previous studies show that c-myc is markedly
upregulated in response to superoxide dismutase defi-
ciency suggesting that early upregulation of c-myc may
play a role in helping cells overcome oxidative stress [45].
In our study, when cells were exposed to 25 mM glucose
in a hypoxic environment, ROS production was markedly
attenuated. Since high glucose may prevent mitochon-
drial dysfunction and be protective against hypoxic injury
[46], ROS levels may be correspondingly reduced result-
ing in lower c-myc transcript levels. Our results suggest
that induction of c-myc is dependent on the quantity of
ROS produced and the susceptibility of the cells to injury
by ROS.
The stimulation of glycolysis in hypoxic cells is driven,
in part, by an increased rate of glucose transport [47].
Consistent with their concordant actions in other aspects
of glucose metabolism, the glucose transporter, glut-1, is
transactivated by both c-myc and Hif-1α [15]. Its overex-
pression correlates with poor prognosis and tumor
aggressiveness in cancer patients [48]. Our results show
an early 2-fold increase in glut-1 mRNA in response to
hypoxia. This increase was persistent, with increased
expression as long as the cells remained hypoxic. Interest-
ingly, hypoxic cells grown in low glucose demonstrated a
3-fold increase in glut-1 mRNA after 48 h of hypoxia
compared to normoxia, paralleling the large increase in
α-enolase mRNA. At all glucose concentrations, tran-
script levels of glut-1 after hypoxia were significantly
greater than those of normoxic cells [26].
Conclusions
In summary, the present study demonstrates the impor-
tant role of α-enolase and MBP-1 in the changes in cell
proliferation and glycolysis induced by hypoxia. Our
results demonstrate that exposure to hypoxia attenuates
translation of MBP-1 and disrupts MBP-1-mediated reg-
ulation of c-myc transcription by inhibiting binding of
MBP-1 to the c-myc P2 promoter, particularly in cells
grown in low glucose concentrations. This allows for
immediate upregulation of c-myc, which may stimulate
aerobic glycolysis and be instrumental in helping MCF-7
cells overcome oxidative stress. Preferential translation of
α-enolase and its post-translational modification may
play a critical role in the adaptation of MCF-7 cells to low
oxygen and increased oxidative stress, particularly under
low glucose concentrations (Table 1). This important
"feedback" mechanism may help transformed cells to
escape the apoptotic cascade, allowing for survival during
limited glucose and oxygen availability. The important
mechanisms modulating preferential translation of α-
enolase or MBP-1 remain to be investigated.
Methods
Cell Culture
MCF-7 cells were purchased from the American Type
Culture Collection (ATCC, USA) and maintained in 5%
CO2 at 37°C in DMEM containing 25 mM glucose and 4
mM glutamine supplemented with 10% charcoal stripped
FBS and 100 U penicillin/streptomysin. For experiments,
cells were plated and allowed to settle overnight. The next
day, cells were washed with glucose-free DMEM medium
and incubated with DMEM containing 1 nM (low), 5 mM
(physiologic), or 25 mM (high) glucose supplemented
with 10% dialyzed FBS (Invitrogen) and 100 U penicillin/
streptomysin at 37°C in a humidified gas-tight sealed
chamber (Billups-Rothenburg, Del Mar, CA) gassed with
1% O2, 5% CO2, and balance N2. Cells were harvested at 0
h (before changing the medium, normoxia control) and at
various times and used for subsequent experimental anal-
ysis.
Cell Proliferation Assay
Cells were plated in a 6-well plate at 40% confluence. Cell
counts and viability were determined by trypan blue
exclusion counting on a hemocytometer at various time
intervals.
Cell Cycle Analysis
Cells were plated in a 60 mm plate at a density of 5 × 105
cells/plate. After 48 h of incubation under hypoxia or
normoxia, the cells were collected in cold PBS, prepared
and stained with the CycleTEST™ Plus DNA Reagent kit
(BD Biosciences), which stains isolated nuclei with pro-
pidium iodide, and analyzed with a flow cytometer.
Lactate Assay
Cells were plated in a 6-well plate at a density of 7.5 × 104
cells/well in 2 ml of medium. The next day, the medium
was suctioned off and cells were rinsed with glucose free/
phenol-red free DMEM and incubated in 1 nM, 5 mM, or
25 mM glucose medium (phenol-red free) at 37°C in a
humidified chamber gassed with 1% O2 and 5% CO2.
Medium was collected and lactate concentrations were
determined by a previously described method [26]. This
method monitors the NADH product at 340 nm after the
NAD-linked conversion of lactate to pyruvate by lactate
dehydrogenase with hydrazine trapping of pyruvate to
ensure the reaction goes to completion. After 30 min of
incubation at 25°C, absorbance was read at 340 nm and
compared to a linear lactate standard curve (2-100 μg/
ml). Medium blanks showed negligible absorbance.Sedoris et al. BMC Cancer 2010, 10:157
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Analysis of ROS Generation
Generation of ROS in MCF-7 cells were assessed by using
the probe 2',7'-dichlorofluorescin diacetate (DCFH-DA)
(Sigma Chemical), a lipid-permeable non-fluorescent
compound that when oxidized by intracellular reactive
oxygen species (ROS), forms the fluorescent compound
2', 7'-dichlorofluorescein (DCF). MCF-7 cells were plated
in a 6-well plate at a density of 7.5 × 104 cells/well in 2 mls
of medium. The next day, the medium was aspirated and
cells were rinsed with glucose free/phenol-red free
DMEM and incubated in 1 nM, 5 mM, or 25 mM glucose
medium (phenol-red free) containing 10 μM DCFH-DA
(final concentration from 10 mM stock of DCFH-DA in
DMSO) at 37°C in a humidified chamber gassed with 1%
O2 and 5% CO2 for 0.5, 1, or 4 h. At the designated time of
analysis, the medium containing the DCFH-DA was
removed and the cells were rinsed with serum-free, phe-
nol-red free medium and lysed with reporter lysis buffer
(Promega). The lysates and media were transferred to a
black 96-well plate and the fluorescence intensity of DCF
was read at 538 nm emission and 485 nm excitation. Due
to leakage of DCF across the cell membrane into the
medium, DCF fluorescence was measured from the
medium and the cells and together represents a qualita-
tive estimation of intracellular ROS formation [49]. Nega-
tive controls containing DMSO instead of DCFH-DA
showed negligible fluorescence.
Western Blotting for α-enolase, MBP-1, and c-Myc
Cells were plated in a 60 mm culture dish at a density of 5
× 105/plate and subjected to the experimental protocol as
previously mentioned. To prepare protein extracts, cells
were collected from each of the three treatment groups
and lysed with Mammalian Extraction Reagent (M-PER)
(Pierce) containing protease (Complete Mini, Roche) and
phosphatase inhibitors (PhosphoStop, Roche). Thirty
micrograms of total cell lysate was separated by SDS-
PAGE on a 4-15% gradient denaturing gel and electrob-
lotted onto PVDF membranes. Gel transfer efficiency and
equal loading of proteins was verified by Ponceau S stain-
ing of PVDF membranes. The membranes were blocked
for 1 h with 5% nonfat milk in phosphate buffered saline
with 0.05% Tween-20 (PBS-T) and incubated overnight at
4 C with an α-enolase (C-19) or c-myc primary antibody
(9E10) (Santa Cruz Biotechnology). After washing with
PBS-T, the membranes were incubated with a horserad-
ish peroxidase (HRP)-conjugated secondary antibody.
Proteins were visualized using standard chemilumines-
cence (ECL) methods (GE Healthcare). Equal loading of
proteins was verified by probing the membrane with a
monoclonal β-actin primary antibody (Sigma Chemical).
All films were scanned with an optical scanner (Epson
Expression 1680) and quantified by measuring the den-
sity of each band using UNSCAN-IT software (Silk Scien-
tific, Inc; Orem, UT). To correct for possible unequal
loading, each band's density was normalized to its β-actin
density. To allow for multiple comparisons between gels,
each sample was compared to its respective 0 h that was
run on the same gel. Calculation of the ratio of α-enolase
to MBP-1 was calculated by dividing the averages of each
protein.
Tyrosine Phosphorylation of α-enolase
To evaluate tyrosine phosphorylation of α-enolase, 500
μg of total protein was immunoprecipitated with 5 μg of
an anti-enolase goat polyclonal antibody (C-19, Santa
Cruz Biotechnology). The protein-antibody-bead com-
plex was washed three times with a buffer containing 1.0
M Tris pH 7.5, 1 M NaCl, 0.5 M EDTA, 1% NP-40, and
protease/phosphatase inhibitors. A control reaction was
done in which the same amount of IgG (goat) was added
in place of anti-enolase antibody. The beads were resus-
pended in Lammelli loading buffer and heated at 95°C for
5 min and centrifuged for 2 min. The resulting superna-
tants were separated by SDS-PAGE and transferred to
PVDF membranes as described above. For detection of
Table 1: Summary of hypoxia-induced changes compared to normoxia
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tyrosine phosphorylation of α-enolase, the membranes
were blocked for 3 h in 5% BSA in PBS-T and incubated
with a monoclonal anti-phosphotyrosine primary anti-
body (PY-20, Santa Cruz Biotechnology) overnight at 4°C.
The membranes were washed and developed as
described above. Verification of equal immunoprecipita-
tion of α-enolase was achieved by stripping the mem-
brane and reprobing for total α-enolase using an anti-
enolase rabbit polyclonal antibody (H-300, Santa Cruz
Biotechnology). Specificity of the immunoprecipitations
was demonstrated by the absence of α-enolase in samples
immunoprecipitated with goat IgG.
RT-PCR
Total RNA was extracted from MCF-7 cells using TriZol
(Invitrogen) reagent according to manufacturer's instruc-
tions. RNA purity was determined by A260/A280 ratio
and quantified by A260. Preparation of cDNA and for-
ward and reverse primers for α-enolase, c-myc, β-actin,
and glut-1 were as previously described [26]. All primers
were designed using Primer Express Software (Applied
Biosystems). RT-PCR was performed for a uniform
amount of cDNA using the Fast 7500 System (Applied
Biosystems). Reactions were diluted 1:2 with SYBR Green
I Master Mix (Applied Biosystems) and amplification by
PCR was as follows: 1 repetition at 50°C for 2 min, 1 repe-
tition at 95°C for 10 min, and 40 repetitions of 95°C for 15
sec and 60°C for 1 min representing the melting, primer
annealing, and primer extension phases of the reaction
respectively. A no template control reaction was run for
each gene to control for DNA contamination of RNA
extracts. Following amplification, a dissociation curve
was performed to provide evidence for a single reaction
product. Message of α-enolase, c-myc, and glut-1 was
compared to the 0 h control to calculate an expression
ratio.
Electrophoretic Mobility Shift Assay
To assemble the P2 promoter of c-myc, a 50 bp oligonu-
cleotide (-52 to +2 relative to the P2 start site on the c-myc
promoter) was radiolabeled using [γ-32P]-dATP with T4
polynucleotide kinase (Gibco BRL). It was annealed to its
complement by heating at 90 C for 10 min in 20 mM Tris-
HCl (pH 7.4), 10 mM Mg Cl2 and slow cooling to room
temperature to form a radiolabeled double stranded
probe. Nuclear extracts were prepared as previously
described [50] from samples taken after 4 or 24 h of
hypoxia from 1 nM, 5 mM, or 25 mM glucose concentra-
tions. The probe (50,000 cpm) was incubated with 5 μg of
nuclear extract in 20 mM Tris-HCl (pH 7.4), 140 mM
KCl, 2.5 mM MgCl2, 1 mM DTT, 8% v/v glycerol, and 0.2
mM PMSF for 30 min at 37 C. In some reactions, 150 nM
of the unlabeled competitor MP2 5'-AGGGATCGCGCT
GAGTATAAAAGCCGGTTTTCGGGG-3' containing
the binding site for MBP-1 or the nonspecific competitor
BEE-1 5'-AGCTGTTCTGAGTGGGG GAGGGGGCT-
GCGCCTGC-3', containing an unrelated consensus
sequence, were added before adding the probe to demon-
strate specificity. A supershift was performed as
described, except that 5 μg of anti-α-enolase polyclonal
antibody (Abcam) was added before addition of the probe
for 30 min at 4°C. The protein-DNA binding reactions
were separated by electrophoresis on a 5% nondenaturing
p o l y a c r y l a m i d e  g e l  a t  r o o m  t e m p e r a t u r e  i n  1 ×  T r i s
borate-EDTA. Complexes were visualized by autoradiog-
raphy.
Data Analysis
All values represent mean ± SEM. Differences between
normoxic and hypoxic samples were determined by a
non-paired t-test (2-tailed). A probability level of p < 0.05
was used to indicate statistical significance.
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